Pharmaceuticals industry

AstraZeneca

AstraZeneca’s numbers are good but trouble in China could drag it down | Nils Pratley

In the world of two weeks ago, AstraZeneca’s share price probably would have enjoyed a strong day on the release of Tuesday’s third-quarter numbers. The profit figure beat forecasts...
Business

‘The UK is at the back of the race of turtles’: Sanofi’s boss on the need to develop new medicines

Paul Hudson, the Briton who leads the French drug firm Sanofi, is “immensely” proud to have carried the...
Business

GSK strikes $2.2bn deal to resolve legal cases in US over heartburn treatment Zantac

The British drugmaker GSK has struck an agreement to make a payment of up to $2.2bn (£1.7bn) to...
England

Pharmacy closures in England threaten plan to use them instead of GPs for some care

High street pharmacies are closing at such an alarming rate that it threatens the drive to use them...
Autonomy

Britain could be a sci-tech superpower – if the Treasury stopped holding it back | Will Hutton

Just how bad is the economy? The chancellor, Rachel Reeves, warns that hard choices on tax, spending and...

No posts to display

Editor Picks

Must Read

Hot Topics